Arrowstreet Capital
IART icon

Arrowstreet Capital’s Integra LifeSciences IART Stock Holding History

Arrowstreet Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
+131,515
New +$1.84M ﹤0.01% 1493
2025
Q1 		– Sell
-13,756
Closed -$312K – 1898
2024
Q4 		$312K Buy
13,756
+913
+7% +$19.9K ﹤0.01% 1617
2024
Q3 		$233K Buy
+12,843
New +$298K ﹤0.01% 1634
2024
Q2 		– Sell
-266,074
Closed -$9.43M – 1642
2024
Q1 		$9.43M Sell
266,074
-193,388
-42% -$7.73M 0.01% 700
2023
Q4 		$20M Sell
459,462
-68,708
-13% -$2.7M 0.02% 420
2023
Q3 		$20.2M Sell
528,170
-53,709
-9% -$2.26M 0.02% 388
2023
Q2 		$23.9M Sell
581,879
-88,084
-13% -$4.24M 0.03% 362
2023
Q1 		$38.5M Sell
669,963
-95
-0% -$5.35K 0.05% 310
2022
Q4 		$37.6M Buy
670,058
+17,677
+3% +$900K 0.05% 284
2022
Q3 		$27.6M Buy
652,381
+137,931
+27% +$7.07M 0.04% 323
2022
Q2 		$27.8M Buy
514,450
+280,004
+119% +$16.8M 0.04% 318
2022
Q1 		$15.1M Buy
234,446
+170,543
+267% +$11.2M 0.02% 456
2021
Q4 		$4.28M Sell
63,903
-118,121
-65% -$7.99M 0.01% 851
2021
Q3 		$12.5M Buy
182,024
+13,360
+8% +$944K 0.02% 664
2021
Q2 		$11.5M Buy
+168,664
New +$11.9M 0.01% 798
2020
Q2 		– Sell
-53,700
Closed -$2.4M – 2370
2020
Q1 		$2.4M Buy
53,700
+42,100
+363% +$2.21M 0.01% 998
2019
Q4 		$676K Buy
+11,600
New +$691K ﹤0.01% 1428
2017
Q2 		– Sell
-154,800
Closed -$6.52M – 1183
2017
Q1 		$6.52M Buy
+154,800
New +$6.61M 0.02% 495
2016
Q4 		– Sell
-348,646
Closed -$14.4M – 2052
2016
Q3 		$14.4M Buy
348,646
+237,668
+214% +$9.96M 0.05% 362
2016
Q2 		$4.43M Buy
+110,978
New +$3.99M 0.01% 616
2016
Q1 		– Sell
-6,000
Closed -$203K – 1418
2015
Q4 		$203K Buy
+6,000
New +$188K ﹤0.01% 1311

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Arrowstreet Capital's IART Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Integra LifeSciences (IART) in Q2 2026: 131,515 shares worth $2.36M. The stake represents ﹤0.01% of the portfolio and ranks #1493 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in IART as recently as Q4 2024.

Arrowstreet Capital first reported a position in IART in Q4 2015 and has held it in 21 quarters since. The position peaked at $38.5M in Q1 2023. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Arrowstreet Capital held 131,515 shares of Integra LifeSciences worth $2.36M as of Q2 2026.
  • Integra LifeSciences was a new Arrowstreet Capital position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1493 holding.
  • Arrowstreet Capital first reported a position in Integra LifeSciences in Q4 2015 and has held it in 21 quarters since.
  • Arrowstreet Capital's Integra LifeSciences position peaked at $38.5M in Q1 2023.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.